Department of Orthopaedic Surgery, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA.
Boston Sports and Shoulder Research Foundation, Waltham, MA, USA; Department of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA, USA.
J Shoulder Elbow Surg. 2024 Jun;33(6S):S55-S63. doi: 10.1016/j.jse.2024.01.027. Epub 2024 Feb 28.
As the indications for reverse total shoulder arthroplasty (RSA) continue to evolve, it has been more commonly utilized for the treatment of glenohumeral osteoarthritis with an intact rotator cuff (GHOA). Given the increased use of RSA for GHOA, it is important to identify factors influential of clinical outcomes. In this study, we sought to identify variables predictive of clinical outcomes following RSA for GHOA.
Patients undergoing primary RSA for GHOA between 2015 and 2020 were retrospectively identified through a prospectively maintained, single surgeon registry. Eligible patients had complete patient-reported outcome measures and range of motion measurements with a minimum 2-year follow-up. Univariate analysis was utilized to compare characteristics and outcome measures of patients with poor and excellent outcomes, which was defined as postoperative American Shoulder and Elbow Surgeons (ASES) scores in the bottom and top quartiles, respectively. Multivariate linear regression was performed to determine factors independently predictive of postoperative ASES score.
A total of 230 patients were included with a mean follow-up of 33.4 months (SD 13.2). The mean age of the study population was 71.9 (SD 6.1). Two hundred twenty-four patients (97.4%) surpassed the minimal clinically important difference and 209 patients (90.1%) achieved substantial clinical benefit for ASES score. Preoperative factors differing between the poor and excellent outcome groups were sex (male: poor 37.9%, excellent 58.6%; P = .041), opioid use (poor 24.1%, excellent 5.2%; P = .009), ASES score (poor 32.9, excellent 41.0; P = .011), and forward elevation (poor 92°, excellent 101°; P = .030). Linear regression demonstrated that Walch B3 glenoids (β 7.08; P = .010) and higher preoperative ASES scores (β 0.14; P = .025) were predictors of higher postoperative ASES score, while postoperative complications (β -18.66; P < .001) and preoperative opioid use (β -11.88; P < .001) were predictive of lower postoperative ASES scores.
Over 90% of patients who underwent RSA for GHOA with an intact rotator cuff experienced substantial clinical benefit. An unsurprising handful of factors were associated with postoperative clinical outcomes; higher preoperative ASES scores were slightly associated with higher postoperative ASES, whereas preoperative opioid use and postoperative complications were associated with lower postoperative ASES. Additionally, Walch glenoid type B3 was associated with higher postoperative ASES, indicating that patients with posterior glenoid defects are not predisposed to poor clinical outcomes following RSA. These results serve as a resource to improve preoperative patient counseling and manage postoperative expectations.
随着反式全肩关节置换术(RSA)适应证的不断发展,其已越来越多地用于治疗肩袖完整的肱骨头下肩关节骨关节炎(GHOA)。鉴于 RSA 在 GHOA 中的应用日益增多,确定影响临床结果的因素非常重要。在这项研究中,我们旨在确定影响 RSA 治疗 GHOA 后临床结果的变量。
通过前瞻性维护的单外科医生登记处,回顾性确定了 2015 年至 2020 年间接受原发性 RSA 治疗 GHOA 的患者。合格患者均具有完整的患者报告的结局测量和运动范围测量值,且随访时间至少为 2 年。采用单变量分析比较了预后不良和预后良好的患者的特征和结局测量值,预后不良和预后良好分别定义为术后美国肩肘外科医生(ASES)评分处于最低四分位数和最高四分位数。进行多元线性回归以确定术后 ASES 评分的独立预测因素。
共纳入 230 例患者,平均随访 33.4 个月(标准差 13.2)。研究人群的平均年龄为 71.9(标准差 6.1)岁。224 例患者(97.4%)超过了最小临床重要差异,209 例患者(90.1%)的 ASES 评分达到了实质性的临床获益。预后不良和预后良好两组之间存在差异的术前因素包括性别(男性:预后不良 37.9%,预后良好 58.6%;P=.041)、阿片类药物使用(预后不良 24.1%,预后良好 5.2%;P=.009)、ASES 评分(预后不良 32.9,预后良好 41.0;P=.011)和前向抬高(预后不良 92°,预后良好 101°;P=.030)。线性回归表明,Walch B3 型肩胛盂(β 7.08;P=.010)和较高的术前 ASES 评分(β 0.14;P=.025)是术后 ASES 评分较高的预测因素,而术后并发症(β-18.66;P<.001)和术前阿片类药物使用(β-11.88;P<.001)是术后 ASES 评分较低的预测因素。
超过 90%的接受 RSA 治疗 GHOA 且肩袖完整的患者经历了实质性的临床获益。有一些意想不到的因素与术后临床结果相关;较高的术前 ASES 评分与较高的术后 ASES 评分略有相关,而术前阿片类药物的使用和术后并发症与较低的术后 ASES 评分相关。此外,Walch 肩胛盂 B3 型与较高的术后 ASES 相关,这表明后肩胛盂缺损的患者在 RSA 后不会产生不良的临床结果。这些结果为改善术前患者咨询和管理术后预期提供了资源。